Instrument Inactif

Autres langues Actavis PLC NYSE

Actions

US00507K1034

Produits pharmaceutiques

Cours en clôture NYSE Autres places de cotation
- ^USD	-

07/04	Allergan Aesthetics inaugure un nouveau centre de formation AMI à Austin	CI
31/03	Allergan Aesthetics lance la quatrième édition du CoolMonth avec des offres exclusives sur CoolSculpting	CI

Autres langues

07/04	Allergan Aesthetics Opens New Ami Training Center in Austin
31/03	Allergan Aesthetics Announces Fourth Annual CoolMonth With Deals On CoolSculpting
30/03	Allergan Aesthetics Presents Findings on Safety and Efficacy of Repeat Trenibote Treatments and Data on Medical Weight Loss Aesthetics Patient Behaviors At the 2026 American Academy of Dermatology Meeting
19/03	Allergan Aesthetics Reveals Evolution in Approach to Modern Aesthetic Treatments with Comprehensive Global Survey and New Educational Solutions
04/03	Allergan Aesthetics Shares Medical Weight Loss Data and the Changing Profile of Patients
12/11	Allergan Aesthetics Unveils New Data at 2025 American Society for Dermatologic Surgery Annual Meeting Showcasing Transformative Innovation and Portfolio Excellence
25/09/25	AllAllergan Aesthetics to Showcase Multimodal Treatment Approach and Continued Commitment to Skin Quality At AMWC Dubai
19/08/25	Allergan Aesthetics Unveils Its Newest Hydration Hero
30/06/25	U.S. Food and Drug Administration Accepts for Review Allergan Aesthetics Premarket Approval Application for Skinvive by Juvederm for the Improvement of Neck Appearance
12/02/25	Allergan Aesthetics to Launch Three New Training Centers in the U.S. Expanding Access to High Quality Aesthetics Training
19/10/24	BOTOX® Cosmetic (onabotulinumtoxinA) Receives FDA Approval for Moderate to Severe Vertical Bands Connecting the Jaw and Neck (Platysma Bands)
27/08/24	Allergan Aesthetics Announces the Launch of Its Next Generation Hydration Product: Skinmedica HA5 Hydra Collagen Replenish + Restore Hydrator
27/06/24	Allergan Aesthetics Debuts Alle Payment Plans
01/04/24	Court Dismisses Class Action Against Biopharmaceutical Company For Failing To Disclose Progress Of Competitor; Second Circuit Affirms Dismissal Of Putative Class Action Against Allergan; Eleventh Circuit Affirms That "Toxic" Lender Qualified As A "Dealer" Under The Exchange Act Due To High-Volume Trading; Delaware Court Of Chancery Invalidates Governance Rights In Stockholder Agreement
05/03/24	Allergan Aesthetics Announces the U.S. FDA Approval of JUVEDERM VOLUMA XC for Injection in the Temple Region to Improve Moderate to Severe Temple Hollowing in Adults over the Age of 21
18/09/23	Allergan Aesthetics Announces Positive Topline Results from Second Phase 3 Study of Onabotulinumtoxina for the Treatment of Platysma Prominence
30/08/23	Allergan Aesthetics Announces the Journal of Cosmetic Dermatology Publishes Data Demonstrating Patient Satisfaction with Natural-Looking Outcomes Following Treatment with OnabotulinumtoxinA (BotoX®? Cosmetic)
15/05/23	Allergan plc Announces U.S. FDA Approval of SKINVIVE™ by JUVÉDERM®
18/01/23	Allergan Aesthetics Announces the Highly Anticipated National Launch of Juvéderm® Volux™ Xc
17/01/23	Allergan Aesthetics Announces the Launch of the Long-Awaited SkinMedica Even & Correct Collection
07/10/22	Allergan Aesthetics to Present Data from Its Leading Aesthetic Portfolio At the 2022 American Society for Dermatologic Surgery Meeting
31/08/22	Allergan Aesthetics Announces the Launch of SkinMedica Firm & Tone Lotion for Body
03/08/22	FDA Approves JUVÉDERM® VOLUX™ XC for Improvement of Jawline Definition
13/06/22	Sirona Biochem Announces Exclusive Global Licensing Agreement with Allergan Aesthetics
20/04/22	Allergan, an AbbVie Company, to Present New Data from its Eye Care Portfolio at the 2022 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting